Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Beltran, Himisha"'
Autor:
Venkadakrishnan VB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Presser AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Singh R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Booker MA; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., Traphagen NA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Boston College, Chestnut Hill, MA, USA., Voss NCE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belmont Hill School, Belmont, MA, USA., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Mizuno K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Puca L; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Idahor O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard University, Cambridge, MA, USA., Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bakht MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Borah AA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Urology, University of California at San Francisco, San Francisco, CA, USA.; Arc Institute, Palo Alto, CA, USA., Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA, USA., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rickman DS; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. himisha_beltran@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. himisha_beltran@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. himisha_beltran@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 08; Vol. 15 (1), pp. 6779. Date of Electronic Publication: 2024 Aug 08.
Autor:
Singh N; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA., Ramnarine VR; Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA, 02215, USA., Song JH; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA.; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, 85724, USA., Pandey R; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA.; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, 85724, USA., Padi SKR; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA.; Department of Molecular Biology and Biophysics, UConn Health Center, Farmington, CT, 06030, USA., Nouri M; Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Olive V; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA.; Department of Medicine, University of Arizona, Tucson, AZ, 85724, USA., Kobelev M; Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Okumura K; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA.; Department of Physiology, University of Arizona, Tucson, AZ, 85724, USA., McCarthy D; Ribomed Biotechnologies, Inc., 8821N. 7th St. STE 300, Phoenix, AZ, 85020, USA., Hanna MM; Ribomed Biotechnologies, Inc., 8821N. 7th St. STE 300, Phoenix, AZ, 85020, USA., Mukherjee P; Epigenomics Core Facility, Weill Cornell Medicine, New York, NY, 10065, USA., Sun B; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, 85724, USA., Lee BR; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA., Parker JB; Department of Obstetrics and Gynecology, Division of Reproductive Science in Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA., Chakravarti D; Department of Obstetrics and Gynecology, Division of Reproductive Science in Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA., Warfel NA; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA.; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, 85724, USA., Zhou M; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA., Bearss JJ; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA., Gibb EA; Decipher Biosciences, Inc, Vancouver, BC, Canada., Alshalalfa M; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94158, USA., Karnes RJ; Department of Urology, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA., Small EJ; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94158, USA., Aggarwal R; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94158, USA., Feng F; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94158, USA., Wang Y; Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Buttyan R; Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Zoubeidi A; Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Rubin M; Department for BioMedical Research, University of Bern, 3008, Bern, Switzerland., Gleave M; Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Slack FJ; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA, 02215, USA., Davicioni E; Decipher Biosciences, Inc, Vancouver, BC, Canada., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA, 02115, USA., Collins C; Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. colin.collins@ubc.ca., Kraft AS; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA. akraft@uacc.arizona.edu.; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, 85724, USA. akraft@uacc.arizona.edu.
Publikováno v:
Nature communications [Nat Commun] 2021 Dec 21; Vol. 12 (1), pp. 7349. Date of Electronic Publication: 2021 Dec 21.
Autor:
Swami N; University of Massachusetts Medical School, Worcester, MA, USA., Hwang WL; Massachusetts General Hospital, Boston, MA, USA; Broad Institute, Cambridge MA, USA., Guo JA; Massachusetts General Hospital, Boston, MA, USA; Broad Institute, Cambridge MA, USA; University of California at San Francisco, San Francisco, CA, USA., Hoffman H; Massachusetts General Hospital, Boston, MA, USA., Abramowitz MC; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA., Elbakouny Z; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Beltran H; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Chipidza F; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Choueiri T; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Pra AD; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA., Huang F; University of California at San Francisco, San Francisco, CA, USA., Kaochar S; Baylor College of Medicine, Houston, TX, USA., Kantoff P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kim DW; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Kishan AU; University of California Los Angeles, Los Angeles, CA, USA., Kobetz E; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA., Marinac C; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Mucci LA; Harvard T. H. Chan School of Public Health, Boston, MA, USA., Muralidhar V; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Pollack A; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA., Sanford NN; University of Texas Southwestern Medical Center, Dallas, TX, USA., Schaeffer EM; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Spratt DE; University of Michigan, Ann Arbor, MI, USA., Zhao SG; University of Michigan, Ann Arbor, MI, USA., Rebbeck TR; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA; Harvard T. H. Chan School of Public Health, Boston, MA, USA., Nguyen PL; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Feng FY; University of California at San Francisco, San Francisco, CA, USA., Mahal BA; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA. Electronic address: bmahal@med.miami.edu., Alshalalfa M; University of California at San Francisco, San Francisco, CA, USA; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA. Electronic address: mohamed.alshalalfa@gmail.com.
Publikováno v:
Cancer genetics [Cancer Genet] 2021 Nov; Vol. 258-259, pp. 61-68. Date of Electronic Publication: 2021 Aug 28.
Autor:
Davies A; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Nouruzi S; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Ganguli D; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Namekawa T; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Thaper D; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Linder S; The Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Karaoğlanoğlu F; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; School of Computing Science, Simon Fraser University, Burnaby, British Columbia, Canada., Omur ME; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Kim S; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Kobelev M; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Kumar S; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Sivak O; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Bostock C; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Bishop J; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Hoogstraat M; The Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Talal A; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Stelloo S; The Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., van der Poel H; The Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Bergman AM; The Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Ahmed M; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Fazli L; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Huang H; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA., Tilley W; Dame Roma Mitchell Cancer Research Labs, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia., Goodrich D; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA., Feng FY; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Gleave M; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., He HH; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Hach F; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; School of Computing Science, Simon Fraser University, Burnaby, British Columbia, Canada., Zwart W; The Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Selth L; Dame Roma Mitchell Cancer Research Labs, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.; Dame Roma Mitchell Cancer Research Labs and Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Flinders Health and Medical Research Institute, Flinders University, College of Medicine and Public Health, Bedford Park, Australia., Zoubeidi A; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. azoubeidi@prostatecentre.com.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada. azoubeidi@prostatecentre.com.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2021 Sep; Vol. 23 (9), pp. 1023-1034. Date of Electronic Publication: 2021 Sep 06.
Autor:
Brady NJ; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Bagadion AM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Singh R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Conteduca V; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Van Emmenis L; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Arceci E; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Pakula H; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Carelli R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Khani F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Urology, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Bakht M; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Sigouros M; Caryl and Israel Englander Institute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA., Bareja R; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Sboner A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Elemento O; Caryl and Israel Englander Institute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Tagawa S; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Nanus DM; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Robinson B; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Urology, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Rickman DS; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. dsr2005@med.cornell.edu.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. dsr2005@med.cornell.edu.
Publikováno v:
Nature communications [Nat Commun] 2021 Jun 07; Vol. 12 (1), pp. 3372. Date of Electronic Publication: 2021 Jun 07.
Autor:
Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Takeda DY; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Hwang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Arafeh R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Arnoff T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Agarwal S; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., O'Connor E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Qiu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Alaiwi SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Corona RI; Department of Obstetrics and Gynecology and the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Fonseca MAS; Department of Obstetrics and Gynecology and the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Giambartolomei C; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Istituto Italiano di Tecnologia, Genova, Italy., Cejas P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Lim K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., He M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Sheahan A; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Nassar A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Brown L; Department of Urology, University of Washington, Seattle, WA, USA., Nguyen HM; Department of Urology, University of Washington, Seattle, WA, USA., Coleman IM; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Kaipainen A; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., De Sarkar N; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Morrissey C; Department of Urology, University of Washington, Seattle, WA, USA., Korthauer K; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Ellis L; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA., Pasaniuc B; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Lawrenson K; Department of Obstetrics and Gynecology and the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Kelly K; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., Zoubeidi A; Vancouver Prostate Centre, Vancouver, BC, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Corey E; Department of Urology, University of Washington, Seattle, WA, USA., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. freedman@broadinstitute.org.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. freedman@broadinstitute.org.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. freedman@broadinstitute.org.
Publikováno v:
Nature communications [Nat Commun] 2021 Mar 30; Vol. 12 (1), pp. 1979. Date of Electronic Publication: 2021 Mar 30.
Autor:
Conteduca V; Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Ku SY; Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Puca L; Weill Cornell Medicine, New York, New York., Slade M; Epic Sciences, Inc., San Diego, California., Fernandez L; Epic Sciences, Inc., San Diego, California., Hess J; Weill Cornell Medicine, New York, New York., Bareja R; Weill Cornell Medicine, New York, New York., Vlachostergios PJ; Weill Cornell Medicine, New York, New York., Sigouros M; Weill Cornell Medicine, New York, New York., Mosquera JM; Weill Cornell Medicine, New York, New York., Sboner A; Weill Cornell Medicine, New York, New York., Nanus DM; Weill Cornell Medicine, New York, New York., Elemento O; Weill Cornell Medicine, New York, New York., Dittamore R; Epic Sciences, Inc., San Diego, California., Tagawa ST; Weill Cornell Medicine, New York, New York., Beltran H; Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. himisha_beltran@dfci.harvard.edu.; Weill Cornell Medicine, New York, New York.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2020 May; Vol. 19 (5), pp. 1157-1164. Date of Electronic Publication: 2020 Mar 03.
Autor:
Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, New York, USA., Romanel A; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy., Conteduca V; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Casiraghi N; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy., Sigouros M; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, New York, USA., Franceschini GM; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy., Orlando F; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy., Fedrizzi T; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy., Ku SY; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA., Dann E; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy., Alonso A; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA., Mosquera JM; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.; Department of Pathology and Laboratory Medicine, and., Sboner A; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA., Xiang J; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA., Elemento O; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA., Nanus DM; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, New York, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA., Tagawa ST; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, New York, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA., Benelli M; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.; Bioinformatics Unit, Hospital of Prato, Prato, Italy., Demichelis F; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2020 Apr 01; Vol. 130 (4), pp. 1653-1668.
Autor:
Tiwari R; Molecular Oncology Laboratory, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, 208016, India., Manzar N; Molecular Oncology Laboratory, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, 208016, India., Bhatia V; Molecular Oncology Laboratory, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, 208016, India., Yadav A; Molecular Oncology Laboratory, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, 208016, India., Nengroo MA; Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, UP, 226031, India., Datta D; Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, UP, 226031, India., Carskadon S; Vattikuti Urology Institute, Department of Urology, Henry Ford Health System, Detroit, MI, 48202, USA., Gupta N; Department of Pathology, Henry Ford Health System, Detroit, MI, 48202, USA., Sigouros M; Division of Medical Oncology, Weill Cornell Medicine, New York, NY, 10065, USA., Khani F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA., Poutanen M; Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland., Zoubeidi A; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Palanisamy N; Vattikuti Urology Institute, Department of Urology, Henry Ford Health System, Detroit, MI, 48202, USA., Ateeq B; Molecular Oncology Laboratory, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, 208016, India. bushra@iitk.ac.in.
Publikováno v:
Nature communications [Nat Commun] 2020 Jan 20; Vol. 11 (1), pp. 384. Date of Electronic Publication: 2020 Jan 20.
Autor:
Persi E; School of Physics and Astronomy, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 69978 Tel Aviv, Israel; erezpersi@gmail.com koonin@ncbi.nlm.nih.gov f.demichelis@unitn.it horn@tau.ac.il.; Center for Bioinformatics and Computational Biology, Institute of Advanced Computer Studies, University of Maryland, College Park, MD 20742.; National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD 20894., Prandi D; Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy., Wolf YI; National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD 20894., Pozniak Y; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel., Barnabas GD; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel., Levanon K; Sheba Cancer Research Center, Chaim Sheba Medical Center, 52621 Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel., Barshack I; Department of Pathology, Chaim Sheba Medical Center, 52621 Ramat Gan, Israel., Barbieri C; Department of Urology, Weill Cornell Medicine, New York, NY 10065.; Englander Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY 10065., Gasperini P; Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy., Beltran H; Englander Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY 10065.; Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065., Faltas BM; Englander Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY 10065.; Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065., Rubin MA; Department for BioMedical Research, University of Bern, Switzerland Center for Precision Medicine, Inselspital, Bern University Hospital, 3008 Bern, Switzerland., Geiger T; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel., Koonin EV; National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD 20894; erezpersi@gmail.com koonin@ncbi.nlm.nih.gov f.demichelis@unitn.it horn@tau.ac.il., Demichelis F; Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy; erezpersi@gmail.com koonin@ncbi.nlm.nih.gov f.demichelis@unitn.it horn@tau.ac.il.; Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065., Horn D; School of Physics and Astronomy, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 69978 Tel Aviv, Israel; erezpersi@gmail.com koonin@ncbi.nlm.nih.gov f.demichelis@unitn.it horn@tau.ac.il.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Aug 20; Vol. 116 (34), pp. 16987-16996. Date of Electronic Publication: 2019 Aug 06.